Metoprolol Succinate Tablet, Extended Release
Product Images NDC 51655-203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 51655-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 203 52 Rev A 09 20)

Label (51655 203 52   Rev A 09 20)
Label for Metoprolol Succinate Extended-Release Tablets USP 50 mg by Northwind Health Company, LLC. The oral dosage form package contains 30 tablets. The label includes storage instructions, manufacturer details, and NDC 51655-203-52.*
FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure diagram depicting the active ingredient Metoprolol succinate. The diagram shows the molecular components and arrangement typical for Metoprolol succinate, including the succinate moiety.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
Forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geographic regions, NYHA classes, ejection fraction levels, ischemic etiology, sex, race, prior myocardial infarction, diabetes, hypertension, and heart rate. The plot compares Metoprolol Succinate Extended-Release Tablets versus placebo effects on each subgroup.*
FDA Label Image

Image-03 (Image 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.